Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lacroix

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Investigational New Drugs|October 1, 2013
A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphomaA Hollebecque, E Deutsch, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2017
Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNAJ Remon, C Caramella, C Jovelet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2021
Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patientsM Aldea, L Cerbone, A Bayle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2011
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safetyC A Gomez-Roca, L Lacroix, C Massard, et al.
Pain|May 26, 2009
The beta3 subunit of the Na+,K+-ATPase mediates variable nociceptive sensitivity in the formalin testMichael L LaCroix-Fralish, Gary Mo, Shad B Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancerF Mosele, B Stefanovska, A Lusque, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2022
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patientsJ Chen, F Facchinetti, F Braye, et al.
Nature Methods|May 11, 2010
Coding of facial expressions of pain in the laboratory mouseDale J Langford, Andrea L Bailey, Mona Lisa Chanda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2013
Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT networkM Beau-Faller, N Prim, A-M Ruppert, et al.
Journal of Medicinal Chemistry|February 16, 2013
Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonistsPanayiotis A Procopiou, John W Barrett, Nicholas P Barton, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Investigational New Drugs|October 1, 2013
A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphomaA Hollebecque, E Deutsch, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2017
Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNAJ Remon, C Caramella, C Jovelet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2021
Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patientsM Aldea, L Cerbone, A Bayle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2011
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safetyC A Gomez-Roca, L Lacroix, C Massard, et al.
Pain|May 26, 2009
The beta3 subunit of the Na+,K+-ATPase mediates variable nociceptive sensitivity in the formalin testMichael L LaCroix-Fralish, Gary Mo, Shad B Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancerF Mosele, B Stefanovska, A Lusque, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2022
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patientsJ Chen, F Facchinetti, F Braye, et al.
Nature Methods|May 11, 2010
Coding of facial expressions of pain in the laboratory mouseDale J Langford, Andrea L Bailey, Mona Lisa Chanda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2013
Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT networkM Beau-Faller, N Prim, A-M Ruppert, et al.
Journal of Medicinal Chemistry|February 16, 2013
Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonistsPanayiotis A Procopiou, John W Barrett, Nicholas P Barton, et al.
Pageof 12